Antonio M. Grimaldi

Antonio M. Grimaldi

Benevento, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 71 publications

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Adjuvant immunotherapy in high-risk stage II melanoma: real-world outcomes from a large multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: April 08, 2026

Cancer in migrant populations: evidence from a regional oncology network.

Cancer in migrant populations: evidence from a regional oncology network.

Journal: BMC public health

Published: January 23, 2026

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Clinical activity and safety of nivolumab in combination with ipilimumab in metastatic melanoma: findings from REALIPINIVO, a real-world study.

Journal: Frontiers in immunology

Published: November 03, 2025

Rescue Surgery for Advanced Stage Lung Cancer: A Systematic Review.

Rescue Surgery for Advanced Stage Lung Cancer: A Systematic Review.

Journal: Thoracic cancer

Published: May 31, 2025

Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.

Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.

Journal: NEJM evidence

Published: September 24, 2024

Cardiac metastasis from urothelial carcinoma: a stealthy precursor.

Cardiac metastasis from urothelial carcinoma: a stealthy precursor.

Journal: European heart journal. Cardiovascular Imaging

Published: October 13, 2023

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.

Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.

Journal: Nature communications

Published: May 15, 2023

Pancreatic Cancer: Beyond Brca Mutations.

Pancreatic Cancer: Beyond Brca Mutations.

Journal: Journal of personalized medicine

Published: October 25, 2022

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 01, 2022

Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression.

Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α Expression.

Journal: Biology

Published: July 13, 2021

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.

Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.

Journal: Cancers

Published: July 05, 2021

Ipilimumab and Stereotactic Radiosurgery with CyberKnife® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience.

Ipilimumab and Stereotactic Radiosurgery with CyberKnife® System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience.

Journal: Cancers

Published: March 05, 2021

Showing 1-12 of 71

Last Updated: 09/26/2026